Subcutaneous Entyvio hits Crohn’s primary endpoint, misses secondary
If approved, the drug could have huge benefits for patients as they could self-administer their therapy from home.
Read More
Tag: endpoint
Chiesi announces two successful sets of asthma data
24% of asthma patients have difficult-to-treat or severe versions of the disease.
Read More
United Theraputics ends esuberaprost trial early
The company kept the announcement short, but said the study did not meet its primary endpoint.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
